Rougetx
Rougetx is a biotech company.
- Website
- rougetx.com
About
RougeTx develops therapies directed at pericytes, a cell type responsible for maintaining the structure and function of blood vessels. Its approach focuses on the upstream drivers of vessel instability rather than downstream symptoms, with the aim of developing disease-modifying treatments for vascular and microvascular disease.
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rougetx"><img src="https://indexed.vc/api/badge/company/rougetx" alt="Rougetx on Indexed.vc" width="260" height="76" /></a>